Stemtech (STEK) Shares Outstanding (Weighted Average) (2020 - 2025)
Stemtech (STEK) has disclosed Shares Outstanding (Weighted Average) for 6 consecutive years, with $150.1 million as the latest value for Q3 2025.
- Quarterly Shares Outstanding (Weighted Average) rose 24.49% to $150.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $150.1 million through Sep 2025, up 24.49% year-over-year, with the annual reading at $118.7 million for FY2024, 42.2% up from the prior year.
- Shares Outstanding (Weighted Average) hit $150.1 million in Q3 2025 for Stemtech, up from $140.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $150.1 million in Q3 2025 to a low of $19.1 million in Q3 2021.
- Historically, Shares Outstanding (Weighted Average) has averaged $78.3 million across 5 years, with a median of $83.5 million in 2023.
- Biggest five-year swings in Shares Outstanding (Weighted Average): soared 279.07% in 2021 and later rose 19.88% in 2024.
- Year by year, Shares Outstanding (Weighted Average) stood at $35.3 million in 2021, then skyrocketed by 30.31% to $46.0 million in 2022, then skyrocketed by 81.4% to $83.5 million in 2023, then soared by 42.2% to $118.7 million in 2024, then grew by 26.46% to $150.1 million in 2025.
- Business Quant data shows Shares Outstanding (Weighted Average) for STEK at $150.1 million in Q3 2025, $140.2 million in Q2 2025, and $118.7 million in Q1 2025.